# Efficacy and Safety of TAK-385 in the Treatment of Endometriosis

> **NCT01458301** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 487 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Placebo
- **DRUG:** TAK-385
- **DRUG:** TAK-385
- **DRUG:** TAK-385
- **DRUG:** Leuprorelin acetate

## Key facts

- **NCT ID:** NCT01458301
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 487 (ACTUAL)
- **Last updated:** 2014-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01458301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01458301, "Efficacy and Safety of TAK-385 in the Treatment of Endometriosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01458301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*